Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reiji Yoshimura

Showing results (231-240 of 297) with videos related to

Pageof 30
Sort By:
Journal of Human Genetics|March 6, 2015
No support for replication of the genetic variants identified by a recent mega-analysis of the treatment response to antidepressantsMasakazu Hatano, Masashi Ikeda, Kenji Kondo, et al.
Psychiatry Research|September 14, 2010
Relationships between stress, social adaptation, personality traits, brain-derived neurotrophic factor and 3-methoxy-4-hydroxyphenylglycol plasma concentrations in employees at a publishing company in JapanKanae Okuno, Reiji Yoshimura, Nobuhisa Ueda, et al.
Schizophrenia Research|May 26, 2009
Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS studyNaoki Goto, Reiji Yoshimura, Junji Moriya, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|May 17, 2013
Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart ReviewYuki Tokutsu, Wakako Umene-Nakano, Takahiro Shinkai, et al.
Psychiatry Research|April 23, 2013
Current smoking rate in patients with psychiatric disorders in Japan: questionnaire surveyWakako Umene-Nakano, Reiji Yoshimura, Tsutomu Hoshuyama, et al.
Schizophrenia Research|October 27, 2009
Gray and white matter volumetric and diffusion tensor imaging (DTI) analyses in the early stage of first-episode schizophreniaJunji Moriya, Shingo Kakeda, Osamu Abe, et al.
Pharmacopsychiatry|March 8, 2018
Efficacy, Tolerability, and Safety of Blonanserin in Schizophrenia: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled TrialsTaro Kishi, Yuki Matsui, Yuki Matsuda, et al.
Human Psychopharmacology|April 15, 2005
An open study of risperidone liquid in the acute phase of schizophreniaReiji Yoshimura, Jun Nakamura, Koji Shinkai, et al.
Neuropsychiatric Disease and Treatment|January 20, 2015
Plasma levels of 3-methoxy-4-hydroxyphenylglycol are associated with microstructural changes within the cerebellum in the early stage of first-episode schizophrenia: a longitudinal VBM studyJoji Nishimura, Shingo Kakeda, Osamu Abe, et al.
Neurology International|April 25, 2022
Volume of Amygdala Subregions and Plasma Levels of Brain-Derived Neurotrophic Factor and Cortisol in Patients with s/s Genotype of Serotonin Transporter Gene Polymorphism of First-Episode and Drug-Naive Major Depressive Disorder: An Exploratory StudyNaomichi Okamoto, Keita Watanabe, Hirofumi Tesen, et al.
Pageof 30

Showing results (231-240 of 297) with videos related to

Sort By:
Pageof 30
Journal of Human Genetics|March 6, 2015
No support for replication of the genetic variants identified by a recent mega-analysis of the treatment response to antidepressantsMasakazu Hatano, Masashi Ikeda, Kenji Kondo, et al.
Psychiatry Research|September 14, 2010
Relationships between stress, social adaptation, personality traits, brain-derived neurotrophic factor and 3-methoxy-4-hydroxyphenylglycol plasma concentrations in employees at a publishing company in JapanKanae Okuno, Reiji Yoshimura, Nobuhisa Ueda, et al.
Schizophrenia Research|May 26, 2009
Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS studyNaoki Goto, Reiji Yoshimura, Junji Moriya, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|May 17, 2013
Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart ReviewYuki Tokutsu, Wakako Umene-Nakano, Takahiro Shinkai, et al.
Psychiatry Research|April 23, 2013
Current smoking rate in patients with psychiatric disorders in Japan: questionnaire surveyWakako Umene-Nakano, Reiji Yoshimura, Tsutomu Hoshuyama, et al.
Schizophrenia Research|October 27, 2009
Gray and white matter volumetric and diffusion tensor imaging (DTI) analyses in the early stage of first-episode schizophreniaJunji Moriya, Shingo Kakeda, Osamu Abe, et al.
Pharmacopsychiatry|March 8, 2018
Efficacy, Tolerability, and Safety of Blonanserin in Schizophrenia: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled TrialsTaro Kishi, Yuki Matsui, Yuki Matsuda, et al.
Human Psychopharmacology|April 15, 2005
An open study of risperidone liquid in the acute phase of schizophreniaReiji Yoshimura, Jun Nakamura, Koji Shinkai, et al.
Neuropsychiatric Disease and Treatment|January 20, 2015
Plasma levels of 3-methoxy-4-hydroxyphenylglycol are associated with microstructural changes within the cerebellum in the early stage of first-episode schizophrenia: a longitudinal VBM studyJoji Nishimura, Shingo Kakeda, Osamu Abe, et al.
Neurology International|April 25, 2022
Volume of Amygdala Subregions and Plasma Levels of Brain-Derived Neurotrophic Factor and Cortisol in Patients with s/s Genotype of Serotonin Transporter Gene Polymorphism of First-Episode and Drug-Naive Major Depressive Disorder: An Exploratory StudyNaomichi Okamoto, Keita Watanabe, Hirofumi Tesen, et al.
Pageof 30